Lupin launches generic Onfi

Press enter to search
Close search
Open Menu

Lupin launches generic Onfi

By Sandra Levy - 05/10/2019
Lupin is introducing its generic Onfi (clobazam tablets). The product, which was previously approved by the Food and Drug Administration, will be available in 10-mg and 20-mg dosage strengths.

Lupin’s generic of Lundbeck’s branded drug is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients 2 years of age or older.

Clobazam tablets in 10- and 20-mg strength have a market value of roughly $479 million, according to March 2019 IQVIA data.

RELATED TOPICS